JPRN-jRCT2080220278未知2 期
DU-176b Phase IIb Clinical Study (Deep Vein Thrombosis) -Randomized, Dose-ranging, Parallel-group, Double-Blind Study in Patients Undergoing Total Knee Arthroplasty with Placebo Control
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 500 人开始时间: 2006年7月14日最近更新:
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 84age old（—）
- 性别
- All
入选标准
- •Patients undergoing unilateral total knee arthroplasty
- •Patients who are 20-84 years olds
排除标准
- •Subjects with risks of hemorrhage
- •Subjects with thromboembolic risks
- •Subjects who weigh less than 40 kg
研究者
相似试验
未知
2 期
DU-176b Phase IIb clinical study (venous thromboembolism): Japan-Taiwan multicenter randomized double-blind dose-finding study using Enoxaparin as a reference in patients undergoing total hip replacementPatients undergoing total hip arthroplastyJPRN-jRCT2080220798DAIICHISANKYO Co.,Ltd.210
未知
3 期
DU-176b Phase III Clinical Study (Venous Thromboembolism) Randomized Double-Blind Study of DU-176b in Patients Undergoing Total Hip Arthroplasty with Enoxaparin as an Active ControlJPRN-jRCT2080220743DAIICHISANKYO Co.,Ltd.600
未知
3 期
DU-176b Phase III Clinical Study (Venous Thromboembolism) -A multicenter, Randomized, Unblinded Study of DU-176b in Patients Undergoing Hip Fracture Surgery with Enoxaparin as a referencePatients undergoing hip fracture surgeryJPRN-jRCT2080220770DAIICHISANKYO Co.,Ltd.90
未知
3 期
DU-176b Phase 3 Clinical Study (Venous Thromboembolism) -Randomized Double-Blind Study of DU-176b in Patients Undergoing Total Knee Arthroplasty with Enoxaparin as an Active ControlJPRN-jRCT2080220701DAIICHISANKYO Co.,Ltd.520
未知
2 期
Phase III Clinical Study of DU-176b (non-valvular atrial fibrillation): Japanese, Multicenter, Open-label Study of DU-176b in Patients with non-valvular atrial fibrillation and Severe Renal Impairmenton-valvular atrial fibrillationJPRN-jRCT2080221674DAIICHI SANKYO Co.,Ltd.90